%0
Generic
%T
Phase I dose escalation of the oral histone deacetylase inhibitor (HDACi) resminostat in combination with FOLFIRI in colorectal cancer (CRC) patients: The SHORE trial.
%A Schulze-Bergkamen, Henning
%A Jaeger, Dirk
%A Kopp, Hans-Georg
%A Mayer, Frank
%A Bitzer, Michael
%A Mais, Anna
%A Resemann, Karin
%A Hauns, Bernhard
%A Asche, Julia
%A Henning, Stefan W.
%A Hentsch, Bernd
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2013
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2